Program Goals

There is a large population of at-risk patients who currently do not have access to the clinical resources for optimal management of the factors that promote cardiovascular diseases. The goal of PACT is to comprehensively evaluate these patients and to provide them with the most effective measures to impede the progression of atherosclerosis. Multiple treatment modalities are explored for every patient to determine the optimum approach. Patients also have access to research protocols and clinical trials.

Recent clinical trials have demonstrated that reducing cholesterol levels prevents cardiovascular disease and lowers total mortality. Other studies, using multiple research methods over several decades, confirm the evidence linking risk factors and cardiovascular disease. Angiographic and functional studies in atherosclerosis show that aggressive risk-factor modification retards the progression of vascular disease and stabilizes vulnerable plaque. Comprehensive risk assessment and therapy is now recognized as an integral part of care for patients with cardiovascular disease and those at high risk.